Mylan CEO Bresch on Brexit Exposure, Regulation

Heather Bresch, chief executive officer at Mylan, discusses the company's business in the U.K., exposure to Brexit, the importance of generics to the pharmaceutical industry, the effects of U.S. regulation, and drug pricing. She speaks with Bloomberg's David Westin on "Bloomberg ‹GO›." (Source: Bloomberg)

Bloomberg Markets: Balance of Power 9/22/2017
44:48 - Guests include: Terry Haines, Evercore ISI senior political strategist, and Fred Hochberg, former Export-Import Bank chairman and president. (Source: Bloomberg)
  • The Main Takeaways From Theresa May's Speech in Florence
  • U.K.'s May Offers EU Concessions in Brexit Speech
  • May Promises U.K. Will Pay Budget Commitments